HomeBXP • LON
Beximco Pharmaceuticals GDR
GBX 37.25
Mar 18, 5:30:00 PM UTC · GBX · LON · Disclaimer
StockGB listed securityBD headquartered
Previous close
GBX 38.50
Day range
GBX 37.25 - GBX 39.00
Year range
GBX 33.30 - GBX 45.00
Avg Volume
53.08K
P/E ratio
-
Dividend yield
-
Market news
Financials
Income Statement
Revenue
Net income
(BDT)Dec 2023Y/Y change
Revenue
10.90B10.24%
Operating expense
2.76B8.36%
Net income
1.43B15.88%
Net profit margin
13.155.12%
Earnings per share
EBITDA
2.63B11.03%
Effective tax rate
22.08%
Total assets
Total liabilities
(BDT)Dec 2023Y/Y change
Cash and short-term investments
1.73B16.97%
Total assets
70.63B1.89%
Total liabilities
21.58B-8.51%
Total equity
49.04B
Shares outstanding
446.11M
Price to book
0.00
Return on assets
7.63%
Return on capital
9.34%
Net change in cash
(BDT)Dec 2023Y/Y change
Net income
1.43B15.88%
Cash from operations
1.76B4.00%
Cash from investing
-599.98M11.88%
Cash from financing
-1.01B-57.17%
Net change in cash
151.94M-59.36%
Free cash flow
2.33B26.94%
About
Founded
1976
Employees
1,324
Discover more
You may be interested in
This list is generated from recent searches, followed securities, and other activity. Learn more

All data and information is provided “as is” for personal informational purposes only, and is not intended to be financial advice nor is it for trading purposes or investment, tax, legal, accounting or other advice. Google is not an investment adviser nor is it a financial adviser and expresses no view, recommendation or opinion with respect to any of the companies included in this list or any securities issued by those companies. Please consult your broker or financial representative to verify pricing before executing any trades. Learn more
Search
Clear search
Close search
Google apps
Main menu